• BIVDA members area

Members' Press Releases

DEMAND FOR GENETIC TESTING DRIVES GROWTH FOR AWARD WINNING ELUCIGENE DIAGNOSTICS

30 percent growth and innovation products wins Manchester company BVCA award 

Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics. The Manchester-based company has been selected as the winner of the Venture-backed Management Team 2017 award for the Northwest in the prestigious British Private Equity & Venture Capital Association (BVCA) awards. Over the last two years it has seen 30 per cent year on year growth, and 85 percent of its revenue is coming from a growing international customer-base.

Read the rest of entry »

New Blood Collection Tubes Stabilise Nucleated Blood Cells

The new Streck Cell-Free DNA BCT® CE blood collection tubes, now available in the UK from Alpha Laboratories, contain a preservative that stabilises nucleated blood cells. This unique stabilisation prevents the release of genomic DNA (gDNA), allowing isolation of high-quality cell-free DNA (cfDNA) samples.

Read the rest of entry »

Protect Your Samples from Acidification When Shipped On Dry Ice

The new ProtectR® tubes, now available from Alpha Laboratories, have the only container closure system engineered to be CO2 resistant. This prevents costly damage to molecular and cellular solutions when shipping or storing samples on dry ice. Standard centrifuge tubes do not provide a reliable barrier against CO2 and even during short term dry ice storage can result in acidification of samples, with a decrease in pH by as much as 2.5 pH units. This acidification can affect the integrity and reproducibility of samples, and may result in a loss of protein activity.

Read the rest of entry »

Isohelix Double Registers its DNA Saliva and Buccal Cell Collectors with the Chinese CFDA.

  

Isohelix announces that their range of GenefiX DNA Saliva and Isohelix DNA Buccal Cell Collectors are both registered with the CFDA in the People’s Republic of China as certified IVD medical devices. The dual registration allows Isohelix and its partners, to substantially develop this territory with the knowledge of a 'full and wide market clearance', elevating Isohelix as a manufacturer of DNA and RNA Saliva Collection products in one of the largest international markets. 

Read the rest of entry »

Radiometer sponsors World Sepsis Day 2017

In continuation of Radiometer’s commitment to the fight against sepsis – one of the world’s deadliest diseases - Radiometer is proud to sponsor World Sepsis Day for the second consecutive year.

Read the rest of entry »

In Brief This Week: VolitionRx, Bio-Techne, Biocept, Meridian Bioscience, and More

NEW YORK (360Dx) – VolitionRx reported a second quarter net loss of $3.5 million, or $.13 per share, compared to a net loss of $2.9 million, or $.13 per share, a year ago. The company said it had $16.5 million in cash and cash equivalents on June 30. During the quarter, it initiated regulatory approval for its tests in Taiwan and Singapore, and noted that if it gets approval in Singapore, it would provide VolitionRx access to nine other South Asian markets. The company also established a wholly owned US subsidiary, Volition America, based in Austin, Texas.

Read the rest of entry »

Patients Suspected of Sepsis No Longer Need to Wait 5 Days to Rule out Bloodstream Infection with Momentum Bioscience's ETGA® Technology

A study showing how rapid negative exclusion of blood cultures by a molecular method, Cognitor® Minus, can aid antimicrobial stewardship. 

UK study in general blood culture of 246 patients with suspected sepsis. In 74% of cases where Cognitor® Minus gave a negative result there was a positive antimicrobial stewardship outcome:

- Either cessation of antibiotics
- Switching from intravenous to oral forms
- Discharge or leaving patients at home
- In some cases antibiotics were not started

Read the rest of entry »

Biofortuna closes £1.6M funding round

Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has raised £1.6M in its latest funding round. The new funding –supported by current investor Foresight VCTs and members of the senior management team – will allow the company to take its ReadyPlex™ rapid blood group genotyping assays into clinical trials and commercialisation, as well as invest in additional resources in its contract manufacturing infrastructure. 

Read the rest of entry »

Safe, Easy UN3373 Sample Transport

The latest addition to the SpeciSafe® range, from Alpha Laboratories,  is a  pack to enclose two paediatric blood or serum tubes. This extends the existing 1, 3, 6 and 10 serum vial packs. The dual serum tube pack also includes two stands to secure tubes for opening on the bench. In addition this versatile design can accommodate a single 1.2ml Monovette tube.

Read the rest of entry »

EKF Diagnostics publishes ‘Diabetes and HbA1c testing’ guide

Cardiff, UK – 17th July 2017 – EKF Diagnostics, the global in vitro diagnostics company, has published a guide to ‘Diabetes and HbA1c testing’ which can be found at EKF’s new Diabetes Portal (www.ekfdiagnostics.com/diabetes-portal.html). This new educational guide draws on EKF’s expertise in the diagnosis and monitoring of diabetes and associated conditions. It provides an overview of the global diabetes ‘epidemic’, symptoms and complications, through to discussion on methods for diagnosis and monitoring using both glucose and HbA1c testing, with consideration given to factors influencing their measurement.

Read the rest of entry »

Pages: Previous1234567...30NextReturn Top

Archive